MannKind | MNKD - Trade Debtors


MannKind reported $43.21M in Trade Debtors for its fiscal quarter ending in June of 2026.





Trade Debtors Change Date
Adma Biologics USD 135.86M 22.57M Mar/2026
BioCryst Pharmaceuticals USD 110.76M 3.94M Jun/2026
Eli Lilly USD 23.48B 2.3B Jun/2026
Halozyme Therapeutics USD 453.33M 4.66M Jun/2026
Insmed USD 215.32M 36.77M Jun/2026
Karyopharm Therapeutics USD 23.36M 2.82M Mar/2026
MacroGenics USD 10.42M 2.95M Mar/2026
MannKind USD 43.21M 15.07M Jun/2026
Merck USD 12.21B 435M Mar/2026
Novavax USD 106.45M 72.27M Dec/2025
Novo Nordisk DKK 17.56B 82.7B Jun/2026
Pfizer USD 16.19B 19M Jun/2026
Sanofi EUR 492M 10M Jun/2026
Xencor USD 42.23M 30.23M Jun/2026